DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$25.83
Tradestie Score
61
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+31.4%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$131.62
|
$3.98B | - | 60 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$42.23
|
$3.92B | - | 64 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$113.51
|
$3.91B | - | 57 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.12
|
$3.83B | - | 56 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$18.50
|
$3.68B | - | 56 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$125.59
|
$3.67B | - | 55 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.95
|
$3.59B | 12.7 | 63 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$25.97
|
$3.58B | 11.4 | 57 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$319.55
|
$3.49B | 40.7 | 60 | Compare |
More DNLI Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry